Jian Wang

Division Manager @Health Canada Santé Canada

Ottawa, ON, CA
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Sep 2020 — Present

Division Manager @Health Canada Santé Canada

View department →

CA

Clinical Evaluation Division – Radiopharmaceuticals and Haematology in Centre for Evaluation of Radiopharmaceuticals & Biotherapeutics (CERB), Biologic and Radiopharmaceutical Drugs Directorate (BRDD), Health Canada The division has regulatory responsibility for assessing non-clinical, pharmacological and clinical data for biological drugs, including advanced therapies, gene therapies and biosimilars, for the treatment of malignant and non-malignant haematologic diseases, and COVID 19. The Division also regulates diagnostic and therapeutic radiopharmaceuticals for all clinical indications.

EDUCATION

1977 — 1982

Harbin Medical University 哈尔滨医科大学

MD, medicine

1985 — 1989

The University of British Columbia / UBC

PhD, Physiology

ABOUT JIAN WANG

Experienced Head with a demonstrated history of working in the government administration. Skilled in Biosimilars, Biotechnology, Life Sciences, and Radiopharmaceuticals. Other key areas: regulatory and operational effectiveness; strategic advice and planning to stakeholders and policy implementation.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.